| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 19.041 | 26.164 | 30.550 | 33.085 | 33.966 |
| Total Income - EUR | - | - | - | - | - | 19.041 | 26.370 | 37.918 | 33.085 | 34.035 |
| Total Expenses - EUR | - | - | - | - | - | 7.637 | 15.755 | 26.640 | 23.596 | 26.305 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 11.404 | 10.615 | 11.278 | 9.488 | 7.731 |
| Net Profit/Loss - EUR | - | - | - | - | - | 11.019 | 10.204 | 10.909 | 9.197 | 6.832 |
| Employees | - | - | - | - | - | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Damvic Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.020 | 8.557 | 18.278 | 13.763 | 11.779 |
| Current Assets | - | - | - | - | - | 10.517 | 12.981 | 12.426 | 2.997 | 8.625 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 515 | 1.028 | 10.280 | 980 | 11 |
| Cash | - | - | - | - | - | 10.002 | 11.953 | 2.146 | 2.017 | 8.614 |
| Shareholders Funds | - | - | - | - | - | 11.060 | 21.019 | 10.957 | 11.112 | 17.882 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 486 | 588 | 20.331 | 5.852 | 3.392 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Damvic Med S.r.l.